Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

EDITORIAL [Hot Topic: Nuclear Image-Guided Personalized Treatment and Prevention of Cancers] promotion: free to download

Volume:19   Issue:20
Pp: 3253-3254
David J. Yang, Fanlin Kong, Lie-Hang Shen, Tomio Inoue and Saad Zakko
DOI: 10.2174/092986712801215892

Design of Peptide Imaging Agents for Whole-body and Intraoperative Molecular Imaging

Volume:19   Issue:20
Pp: 3255-3265
J. A. Moss, A. L. Vavere and A. Azhdarinia
DOI: 10.2174/092986712801215856

Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology

Volume:19   Issue:20
Pp: 3271-3281
Fan-Lin Kong and David J. Yang
DOI: 10.2174/092986712801215946

Radiolabelled Agents for PET Imaging of Tumor Hypoxia open access plus

Volume:19   Issue:20
Pp: 3282-3289
H. Kurihara, N. Honda, Y. Kono and Y. Arai
DOI: 10.2174/092986712801215964

Bone Target Radiotracers for Palliative Therapy of Bone Metastases

Volume:19   Issue:20
Pp: 3290-3300
K. Ogawa and K. Washiyama
DOI: 10.2174/092986712801215865

Radiolabeled RGD Peptides as Integrin alpha(v)beta3–targeted PET Tracers

Volume:19   Issue:20
Pp: 3301-3309
U. Tateishi, T. Oka and T. Inoue
DOI: 10.2174/092986712801215937

Molecular Imaging Kits for Hexosamine Biosynthetic Pathway in Oncology

Volume:19   Issue:20
Pp: 3310-3314
David J. Yang, Fan-Lin Kong, Takashi Oka and Jerry L. Bryant
DOI: 10.2174/092986712801215900

Radiolabeled Nucleosides for Predicting and Monitoring the Cancer Therapeutic Efficacy of Chemodrugs

Volume:19   Issue:20
Pp: 3315-3324
C.-Y. Wu, H.-E. Wang, M.-H. Lin, L.-S. Chu and R.-S. Liu
DOI: 10.2174/092986712801215955

Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives

Volume:19   Issue:20
Pp: 3325-3336
A. Martelli, L. Testai, A. Marino, M. C. Breschi, F. Da Settimo and V. Calderone
DOI: 10.2174/092986712801215928

The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR Mutation

Volume:19   Issue:20
Pp: 3337-3352
A. Sgambato, F. Casaluce, P. Maione, A. Rossi, E. Rossi, A. Napolitano, G. Palazzolo, M. A. Bareschino, C. Schettino, P. C. Sacco, F. Ciadiello and C. Gridelli
DOI: 10.2174/092986712801215973

Designed Multiple Ligands: Basic Research vs Clinical Outcomes open access plus

Volume:19   Issue:20
Pp: 3353-3387
L. Costantino and D. Barlocco
DOI: 10.2174/092986712801215883

Emerging Anticoagulants

Volume:19   Issue:20
Pp: 3388-3416
B. Kennedy, F. S. Gargoum, L. Kennedy, F. Khan, D. R. Curran and T. M. O’Connor
DOI: 10.2174/092986712801215847

Nonanolides of Natural Origin: Structure, Synthesis, and Biological Activity

Volume:19   Issue:20
Pp: 3417-3455
P. Sun, S. Lu, T. V. Ree, K. Krohn, L. Li and W. Zhang
DOI: 10.2174/092986712801215874